Recent Finacing
Recent Raise
SPR Therapeutics develops and commercializes FDA-cleared peripheral nerve stimulation systems—including the 60-day SPRINT PNS, 30-day SMARTPATCH, and implantable MICROPULSE—using percutaneous leads and wearable stimulators for acute and chronic pain.